Mouwasat Medical Services Company (4002.SR)
Saudi - Saudi Delayed price. Currency in SAR
Add to watchlist
At close: 03:19PM AST
Currency in SAR
Valuation measures4
| Market cap (intra-day) | 21.52B |
| Enterprise value | 22.04B |
| Trailing P/E | 32.41 |
| Forward P/E | 27.47 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 7.79 |
| Price/book (mrq) | 6.24 |
| Enterprise value/revenue | 7.97 |
| Enterprise value/EBITDA | 21.99 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.44 |
| 52-week change 3 | -8.50% |
| S&P500 52-week change 3 | 23.49% |
| 52-week high 3 | 144.00 |
| 52-week low 3 | 92.50 |
| 50-day moving average 3 | 128.59 |
| 200-day moving average 3 | 116.19 |
Share statistics
| Avg vol (3-month) 3 | 328.02k |
| Avg vol (10-day) 3 | 304.69k |
| Shares outstanding 5 | 200M |
| Implied shares outstanding 6 | 203.83M |
| Float 8 | 94.93M |
| % held by insiders 1 | 52.50% |
| % held by institutions 1 | 6.41% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 1.75 |
| Forward annual dividend yield 4 | 1.63% |
| Trailing annual dividend rate 3 | 1.75 |
| Trailing annual dividend yield 3 | 1.51% |
| 5-year average dividend yield 4 | 1.51 |
| Payout ratio 4 | 45.18% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 28 May 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 08 Aug 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 23.97% |
| Operating margin (ttm) | 27.02% |
Management effectiveness
| Return on assets (ttm) | 9.27% |
| Return on equity (ttm) | 20.15% |
Income statement
| Revenue (ttm) | 2.76B |
| Revenue per share (ttm) | 13.82 |
| Quarterly revenue growth (yoy) | 8.80% |
| Gross profit (ttm) | N/A |
| EBITDA | 979.62M |
| Net income avi to common (ttm) | 662.66M |
| Diluted EPS (ttm) | 3.32 |
| Quarterly earnings growth (yoy) | 3.00% |
Balance sheet
| Total cash (mrq) | 356.6M |
| Total cash per share (mrq) | 1.78 |
| Total debt (mrq) | 854.97M |
| Total debt/equity (mrq) | 23.73% |
| Current ratio (mrq) | 2.14 |
| Book value per share (mrq) | 17.24 |
Cash flow statement
| Operating cash flow (ttm) | 867.12M |
| Levered free cash flow (ttm) | 247.32M |
© 2024 Yahoo. All rights reserved.